Table 2 Dissection of the anomalous exponent β and generalised diffusion coefficient Kβ for each of the three diffusion regimes (subdiffusive, Brownian and superdiffusive) and their percentage
Anomalous exponent β and generalised diffusion coefficient Kβ | |||||||||
---|---|---|---|---|---|---|---|---|---|
Experimental condition | Subdiffusive | Brownian | Superdiffusive | ||||||
% | Kβ | β | % | Kβ | β | % | Kβ | β | |
CF®640-BTX | 19.44 ± 2.14 | 0.062 ± 0.002 | 0.78 ± 0.01 | 33.47 ± 2.50 | 0.149 ± 0.005 | 1.00 ± 0.01 | 47.09 ± 3.37 | 0.530 ± 0.02 | 1.28 ± 0.01 |
CF®640-BTX upon cholesterol depletion (CDx) | 28.28 ± 2.56 | 0.051 ± 0.002 | 0.77 ± 0.01 | 31.34 ± 2.83 | 0.118 ± 0.006 | 0.97 ± 0.01 | 40.39 ± 4.91 | 0.379 ± 0.031 | 1.31 ± 0.01 |
CF®680-BTX | 15.01 ± 2.14 | 0.062 ± 0.006 | 0.80 ± 0.01 | 29.06 ± 3.58 | 0.130 ± 0.010 | 1.01 ± 0.01 | 55.92 ± 5.00 | 0.662 ± 0.074 | 1.34 ± 0.02 |
fPEG-Chol | 5.34 ± 0.89 | 0.124 ± 0.007 | 0.77 ± 0.01 | 15.65 ± 1.12 | 0.292 ± 0.011 | 1.02 ± 0.01 | 79.01 ± 1.62 | 1.689 ± 0.057 | 1.33 ± 0.01 |
CF®680-BTX (+fPEG-Chol) | 13.01 ± 2.01 | 0.095 ± 0.006 | 0.74 ± 0.01 | 27.50 ± 2.31 | 0.345 ± 0.014 | 1.01 ± 0.01 | 59.50 ± 3.12 | 1.475 ± 0.069 | 1.29 ± 0.01 |
fPEG-Chol (+CF®680-BTX) | 10.96 ± 0.86 | 0.353 ± 0.005 | 0.77 ± 0.01 | 30.30 ± 1.66 | 0.868 ± 0.009 | 1.01 ± 0.01 | 58.74 ± 2.25 | 2.482 ± 0.033 | 1.26 ± 0.01 |